Tibor Vántus

1.4k total citations
29 papers, 1.2k citations indexed

About

Tibor Vántus is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Tibor Vántus has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Tibor Vántus's work include Neuroendocrine Tumor Research Advances (8 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Cellular transport and secretion (4 papers). Tibor Vántus is often cited by papers focused on Neuroendocrine Tumor Research Advances (8 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Cellular transport and secretion (4 papers). Tibor Vántus collaborates with scholars based in Hungary, Germany and Belgium. Tibor Vántus's co-authors include Jackie R. Vandenheede, Johan Van Lint, An Rykx, Attila Mócsai, Thomas Seufferlein, Clifford A. Lowell, Zoltán Jakus, Erzsébet Ligeti, Giorgio Berton and Gÿorgý Kéri and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Tibor Vántus

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tibor Vántus Hungary 15 673 280 182 143 138 29 1.2k
Jay Prendergast United States 10 527 0.8× 395 1.4× 192 1.1× 195 1.4× 85 0.6× 10 1.1k
Zhenyi Ma China 20 867 1.3× 256 0.9× 177 1.0× 207 1.4× 226 1.6× 49 1.4k
Anthony Valentijn United Kingdom 24 1.0k 1.5× 364 1.3× 362 2.0× 206 1.4× 77 0.6× 33 1.9k
Abdelhadi Rebbaa United States 21 1.0k 1.5× 272 1.0× 293 1.6× 239 1.7× 134 1.0× 46 1.6k
Laura Asnaghi United States 20 924 1.4× 142 0.5× 230 1.3× 218 1.5× 95 0.7× 38 1.4k
Mikiro Takaishi Japan 23 701 1.0× 701 2.5× 296 1.6× 176 1.2× 63 0.5× 45 1.7k
Oliver Rausch United Kingdom 16 1.1k 1.6× 300 1.1× 233 1.3× 137 1.0× 50 0.4× 31 1.6k
Severine Gharbi Spain 16 919 1.4× 200 0.7× 174 1.0× 244 1.7× 69 0.5× 21 1.3k
Richard T. Pickard United States 14 536 0.8× 449 1.6× 176 1.0× 189 1.3× 52 0.4× 20 1.3k
Linda Julian United Kingdom 8 592 0.9× 198 0.7× 152 0.8× 174 1.2× 46 0.3× 15 970

Countries citing papers authored by Tibor Vántus

Since Specialization
Citations

This map shows the geographic impact of Tibor Vántus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tibor Vántus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tibor Vántus more than expected).

Fields of papers citing papers by Tibor Vántus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tibor Vántus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tibor Vántus. The network helps show where Tibor Vántus may publish in the future.

Co-authorship network of co-authors of Tibor Vántus

This figure shows the co-authorship network connecting the top 25 collaborators of Tibor Vántus. A scholar is included among the top collaborators of Tibor Vántus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tibor Vántus. Tibor Vántus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nguyễn, Minh Tú, et al.. (2023). Protein Kinase D3 (PKD3) Requires Hsp90 for Stability and Promotion of Prostate Cancer Cell Migration. Cells. 12(2). 212–212. 4 indexed citations
2.
Simon‐Szabó, Laura, Zoltán Greff, Csaba Szántai-Kis, et al.. (2015). Novel compounds reducing IRS-1 serine phosphorylation for treatment of diabetes. Bioorganic & Medicinal Chemistry Letters. 26(2). 424–428. 11 indexed citations
3.
Varga, Attila, Zoltán Greff, Krisztina Futosi, et al.. (2015). Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro. PLoS ONE. 10(4). e0124234–e0124234. 9 indexed citations
4.
Szokol, Bálint, Ferenc Baska, Csaba Szántai-Kis, et al.. (2014). Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors. ACS Medicinal Chemistry Letters. 5(4). 298–303. 12 indexed citations
5.
Kéri, Gÿorgý & Tibor Vántus. (2012). Optimization of Important Early ADME(T) Parameters of NADPH Oxidase-4 Inhibitor Molecules. Medicinal Chemistry. 8(2). 174–181. 4 indexed citations
6.
Parajó, Yolanda, Ivana d’Angelo, Anikó Horváth, et al.. (2010). PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors. European Journal of Pharmaceutical Sciences. 41(5). 644–649. 21 indexed citations
7.
Donkó, Ágnes, Anna Orient, Pál Szabó, et al.. (2009). Detection of hydrogen peroxide by lactoperoxidase-mediated dityrosine formation. Free Radical Research. 43(5). 440–445. 4 indexed citations
8.
Horváth, Anikó, Tamás Lóránd, Attila Agócs, et al.. (2009). Comparative Characterization of Experimental and Calculated Lipophilicity and Anti-Tumour Activity of Isochromanone Derivatives. Current Medicinal Chemistry. 17(4). 321–333. 9 indexed citations
9.
Tsuda, Yuko, Shoji Fukushima, Toshio Yokoi, et al.. (2008). New cyclic somatostatin analogues containing a pyrazinone ring: Importance of Tyr for antiproliferative activity. Bioorganic & Medicinal Chemistry Letters. 18(23). 6199–6201. 6 indexed citations
10.
Horváth, Anikó, János Seprődi, Tibor Vántus, et al.. (2007). Effect of New Synthetic Peptides and Peptidomimetics on Angiogenesis. 2006. 249–250. 1 indexed citations
11.
Vántus, Tibor, Didier Vertommen, Xavier Saelens, et al.. (2004). Doxorubicin-induced activation of protein kinase D1 through caspase-mediated proteolytic cleavage: identification of two cleavage sites by microsequencing. Cellular Signalling. 16(6). 703–709. 17 indexed citations
12.
Rykx, An, Line De Kimpe, Tibor Vántus, et al.. (2003). Protein kinase D: a family affair. FEBS Letters. 546(1). 81–86. 194 indexed citations
13.
Lint, Johan Van, An Rykx, Yusuke Maeda, et al.. (2002). Protein kinase D: an intracellular traffic regulator on the move. Trends in Cell Biology. 12(4). 193–200. 190 indexed citations
14.
Lint, Johan Van, An Rykx, Tibor Vántus, & Jackie R. Vandenheede. (2002). Getting to know protein kinase D. The International Journal of Biochemistry & Cell Biology. 34(6). 577–581. 40 indexed citations
15.
Vántus, Tibor, Gÿorgý Kéri, Mindaugas Valius, et al.. (2001). The somatostatin analogue TT-232 induces apoptosis in A431 cells. Cellular Signalling. 13(10). 717–725. 24 indexed citations
16.
Steták, Attila, et al.. (2001). The Antitumor Somatostatin Analogue TT-232 Induces Cell Cycle Arrest through PKCδ and c-Src. Biochemical and Biophysical Research Communications. 285(2). 483–488. 26 indexed citations
17.
Assefa, Zerihun, Mindaugas Valius, Tibor Vántus, et al.. (1999). JNK/SAPK Activation by Platelet-Derived Growth Factor in A431 Cells Requires Both the Phospholipase C-γ and the Phosphatidylinositol 3-Kinase Signaling Pathways of the Receptor. Biochemical and Biophysical Research Communications. 261(3). 641–645. 21 indexed citations
18.
Vántus, Tibor, et al.. (1997). Identification and characterization of an auto-activating MEK kinase from bovine brain: Phosphorylation of serine-298 in the proline-rich domain of the mammalian MEKs. The International Journal of Biochemistry & Cell Biology. 29(8-9). 1071–1083. 2 indexed citations
19.
Kéri, Gÿorgý, Imre Mező, Anikó Horváth, et al.. (1993). Novel Somatostatin Analogs with Tyrosine Kinase Inhibitory and Antitumor Activity. Biochemical and Biophysical Research Communications. 191(2). 681–687. 34 indexed citations
20.
Horváth, Anikó, et al.. (1992). Novel antitumor peptide hormones and their effect on signal transduction. The Journal of Steroid Biochemistry and Molecular Biology. 43(1-3). 105–110. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jay Prendergast Breakdown of academic impact, for papers by Zhenyi Ma Breakdown of academic impact, for papers by Anthony Valentijn Breakdown of academic impact, for papers by Abdelhadi Rebbaa Breakdown of academic impact, for papers by Laura Asnaghi Breakdown of academic impact, for papers by Mikiro Takaishi Breakdown of academic impact, for papers by Oliver Rausch Breakdown of academic impact, for papers by Severine Gharbi Breakdown of academic impact, for papers by Richard T. Pickard Breakdown of academic impact, for papers by Linda Julian
Rankless by CCL
2026